Replies to post #2950 on Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Shares into strong hands that's how I read it. Also this is the surprise info that we had no idea about.

GBP will be responsible for all clinical development and commercialization costs in the GBP territory. In collaboration with Advaxis, GBP will also identify and pay the clinical trial costs for up to 150 patients with cervical cancer for enrollment in Advaxis’ U.S. and GBP’s Asia registrational programs for cervical cancer.

I like the fact that they are going to pay some of the US costs.